Compounds > 2,5-di-tert-butylhydroquinone

2,5-di-tert-butylhydroquinone and tacrolimus

2,5-di-tert-butylhydroquinone has been researched along with tacrolimus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikebuchi, H; Onose, J; Sawada, J; Teshima, R1
Onose, J; Sawada, J; Teshima, R1

Other Studies

2 other study(ies) available for 2,5-di-tert-butylhydroquinone and tacrolimus

ArticleYear
Ca2+-ATPase inhibitors and PKC activation synergistically stimulate TNF-alpha production in RBL-2H3 cells.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1998, Volume: 47, Issue:8

    Topics: Animals; Calcium-Transporting ATPases; Dactinomycin; Dexamethasone; Enzyme Activation; Enzyme Inhibitors; Hydroquinones; Indoles; Leukemia, Basophilic, Acute; Protein Kinase C; Rats; Tacrolimus; Thapsigargin; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1998
Ca2+-ATPase inhibitor induces IL-4 and MCP-1 production in RBL-2H3 cells.
    Immunology letters, 1998, Volume: 64, Issue:1

    Topics: Animals; Antioxidants; Calcium-Transporting ATPases; Chemokine CCL2; Dactinomycin; Dose-Response Relationship, Drug; Hydroquinones; Indoles; Interleukin-4; Mast Cells; Rats; Tacrolimus; Tetradecanoylphorbol Acetate; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1998